A similar phenotype is observed in CD8+TILs from patients with renal cell carcinoma (RCC), colorectal cancer (CRC), and NSCLC that display upregulation of PD-1, TIGIT, Lag-3, and Tim-3 with reduced CD226 expression [43]. Here, CD226 is linked to renal cell carcinoma.